Thanks for sharing.
Not down talking other bio stocks but we can see which way a successful company gets established, it is the PH-way. Licence cutting edge tech from the best by guaranteeing to take it to the patients if it works, adding real experts with experience and the right ethical attitude to the team. Then the investment money will come. Listen to JC is like listen to IMU's LC. The same attitude, knowledge and passion to drive the tech to success.
I was waiting 5 years at IMU to see it taking off but it was worth it. Will be prepared to stick with CHM LT as well for investment and educational reasons. Had my bowl cancer test returned positive, no alarm yet but one never knows. Always good to know what treatment is available and in development.
Will hold a core and trade the ups and downs with some extra coins like I do at IMU. Very important reference to currently limitations of CAR-T CD 19, which is IMU's latest project by combining it with its OV CF 33 to get the breakthrough.
I may annoy some here constantly referring to IMU but imo CHM is part of the PH-IMU group with PH and LC on the CHM board, the CoH ties and the way it is managed.
On a very speculative side, should IMU get taken over then the IMU team could re-start here or vice versa.
Side note: I am not so convinced regarding PH's latest licence at SUD ( from London ) but it could turn into something too if achieving the results to progress to clinical stage.
GLTA and happy accumulating sub 30c. Got 23 shares yesterday at the close, yeah!
Add to My Watchlist
What is My Watchlist?
